ATNNF yields 1.73% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, ATNNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATNNF + PFE for your $10,000?
Autoneum Holding AG develops and manufactures acoustic and thermal management solutions for the automotive market. It offers multifunctional and lightweight components and systems for noise and heat protection. The company provides engine and e-motor encapsulations, frunks, outer dashes, hoodliners, engine top covers, engine and body-mounted absorbers, and outer trunk floor insulators; and underbody products, including under floor and under engine shields, wheelhouse outer liners, outer tunnel and floor insulators, battery electromagnetic shields, under battery shields, and heatshields, as well as battery and spare wheel pans. It also offers interior floor products comprising inner dashes, needle punch and tufted carpets, floor insulators and mats, inner wheelhouse and trunk floor insulators, and dampers; and other components, such as ultra-silent for underbody systems, di-light for carpet systems, prime-light and IFP-R2 for inner dashes and floor insulators, hybrid-acoustics PET for conventional insulation, mono-liner for wheelhouse outer liners, and relive-1 under the Autoneum Pure label; and measurement systems, as well as performs simulations and tests. The company has operations in Europe, North America, Asia, South America, the Middle East, and Africa. Autoneum Holding AG was founded in 1901 and is headquartered in Winterthur, Switzerland.
Full ATNNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.